Literature DB >> 27075707

TIMP3 Modulates GHR Abundance and GH Sensitivity.

Yue Zhang1, Xiangdong Wang1, Kimberly Loesch1, Larry A May1, George E Davis1, Jing Jiang1, Stuart J Frank1.   

Abstract

GH receptor (GHR) binds GH at the cell surface via its extracellular domain and initiates intracellular signal transduction, resulting in important anabolic and metabolic actions. GH signaling is subject to dynamic regulation, which in part is exerted by modulation of cell surface GHR levels. Constitutive and inducible metalloprotease-mediated cleavage of GHR regulate GHR abundance and thereby modulate GH action. We previously demonstrated that GHR proteolysis is catalyzed by the TNF-α converting enzyme (TACE; ADAM17). Tissue inhibitors of metalloproteases-3 (TIMP3) is a natural specific inhibitor of TACE, although mechanisms underlying this inhibition are not yet fully understood. In the current study, we use two model cell lines to examine the relationships between cellular TACE, TIMP3 expression, GHR metalloproteolysis, and GH sensitivity. These two cell lines exhibited markedly different sensitivity to inducible GHR proteolysis, which correlated directly to their relative levels of mature TACE vs unprocessed TACE precursor and indirectly to their levels of cellular TIMP3. Our results implicate TIMP3 as a modulator of cell surface GHR abundance and the ability of GH to promote cellular signaling; these modulatory effects may be conferred by endogenous TIMP3 expression as well as exogenous TIMP3 exposure. Furthermore, our analysis suggests that TIMP3, in addition to regulating the activity of TACE, may also modulate the maturation of TACE, thereby affecting the abundance of the active form of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27075707      PMCID: PMC4884343          DOI: 10.1210/me.2015-1302

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  77 in total

1.  Adenoviral mediated transfer of TIMP-3 partially prevents glutamate-induced cell death in primary cultured cortical neurons of the rat.

Authors:  Rongbiao Pi; Wei Yin; Suqiu Zheng; Pengxin Qiu; Jian Zhou; Wei Guo; Tao Su; Guangmei Yan
Journal:  Brain Res Mol Brain Res       Date:  2004-08-23

Review 2.  Shedding light on ADAM metalloproteinases.

Authors:  Ari-Pekka J Huovila; Anthony J Turner; Markku Pelto-Huikko; Iivari Kärkkäinen; Rebekka M Ortiz
Journal:  Trends Biochem Sci       Date:  2005-07       Impact factor: 13.807

Review 3.  The ADAMs: signalling scissors in the tumour microenvironment.

Authors:  Gillian Murphy
Journal:  Nat Rev Cancer       Date:  2008-11-13       Impact factor: 60.716

4.  Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase.

Authors:  S J Frank; G Gilliland; A S Kraft; C S Arnold
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736

5.  Characterization of a transformation-sensitive protein in the extracellular matrix of chicken embryo fibroblasts.

Authors:  J Blenis; S P Hawkes
Journal:  J Biol Chem       Date:  1984-09-25       Impact factor: 5.157

6.  Blockade of growth hormone receptor shedding by a metalloprotease inhibitor.

Authors:  J Alele; J Jiang; J F Goldsmith; X Yang; H G Maheshwari; R A Black; G Baumann; S J Frank
Journal:  Endocrinology       Date:  1998-04       Impact factor: 4.736

7.  Determinants of growth hormone receptor down-regulation.

Authors:  Luqin Deng; Kai He; Xiangdong Wang; Ning Yang; Chellappagounder Thangavel; Jing Jiang; Serge Y Fuchs; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2007-05-08

8.  Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation.

Authors:  Kristina Endres; Andreas Anders; Elzbieta Kojro; Sandra Gilbert; Falk Fahrenholz; Rolf Postina
Journal:  Eur J Biochem       Date:  2003-06

9.  Reduced proteolysis of rabbit growth hormone (GH) receptor substituted with mouse GH receptor cleavage site.

Authors:  Xiangdong Wang; Kai He; Mary Gerhart; Jing Jiang; Raymond J Paxton; Ram K Menon; Roy A Black; Gerhard Baumann; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2003-06-26

10.  TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.

Authors:  A Amour; P M Slocombe; A Webster; M Butler; C G Knight; B J Smith; P E Stephens; C Shelley; M Hutton; V Knäuper; A J Docherty; G Murphy
Journal:  FEBS Lett       Date:  1998-09-11       Impact factor: 4.124

View more
  5 in total

Review 1.  Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.

Authors:  John J Kopchick; Reetobrata Basu; Darlene E Berryman; Jens O L Jorgensen; Gudmundur Johannsson; Vishwajeet Puri
Journal:  Nat Rev Endocrinol       Date:  2022-06-24       Impact factor: 47.564

2.  Differentially methylated CpGs in response to growth hormone administration in children with idiopathic short stature.

Authors:  Xiaojian Shao; Catherine Le Stunff; Warren Cheung; Tony Kwan; Mark Lathrop; Tomi Pastinen; Pierre Bougnères
Journal:  Clin Epigenetics       Date:  2022-05-18       Impact factor: 7.259

Review 3.  Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.

Authors:  Christoffer Soendergaard; Jonathan A Young; John J Kopchick
Journal:  Int J Mol Sci       Date:  2017-05-09       Impact factor: 5.923

4.  Growth hormone receptor promotes osteosarcoma cell growth and metastases.

Authors:  Mo Cheng; Wending Huang; Weiluo Cai; Meng Fang; Yong Chen; Chunmeng Wang; Wangjun Yan
Journal:  FEBS Open Bio       Date:  2019-12-18       Impact factor: 2.693

Review 5.  Classical and novel GH receptor signaling pathways.

Authors:  Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2020-08-22       Impact factor: 4.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.